Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification.

导出 LinkOut

翻译打印收藏纠错

作者： Abdul Rashid,Qureshi ^[1] ; Hannes,Olauson ^[1] ; Anna,Witasp ^[1] ; Mathias,Haarhaus ^[1] ; Vincent,Brandenburg ^[2] ; Annika,Wernerson ^[1] ; Bengt,Lindholm ^[1] ; Magnus,Söderberg ^[3] ; Lars,Wennberg ^[4] ; Louise,Nordfors ^[1] ; Jonaz,Ripsweden ^[5] ; Peter,Barany ^[1] ; Peter,Stenvinkel ^[1]

作者单位： Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. ^[1] Department of Cardiology, University Hospital RWTH Aachen, Aachen, Germany. ^[2] Pathology, Drug Safety and Metabolism, AstraZeneca, Mölndal, Sweden. ^[3] Division of Transplantation Surgery, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. ^[4] Division of Radiology, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. ^[5]

DOI 10.1038/ki.2015.194

PMID 26331407

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览66

Kidney international

2015年88卷6期

1356-1364页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification.

Kidney international

相似文献

Kidney international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification.

Kidney international

相似文献

Kidney international

相关期刊

检索历史清除